Episode

Metastatic Breast Cancer — Optimizing the Use of Oral Selective Estrogen Receptor Degraders: Part 2

Podcast
Breast Cancer Update
Published
Nov 29, 2025
Duration seconds
3534
Processing state
not_requested
Canonical source
https://breast-oncology.captivate.fm/episode/5506-oralserdsmbc2025-2
Audio
https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/3a35e67a-a029-4b7d-b0b0-1ef4380ae9c3.mp3
JSON
/v1/public/podcasts/breast-cancer-update-757579/episodes/metastatic-breast-cancer-optimizing-the-use-of-oral-selective-estrogen-receptor-degraders-part-2
Markdown
/podcast/breast-cancer-update-757579/metastatic-breast-cancer-optimizing-the-use-of-oral-selective-estrogen-receptor-degraders-part-2.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/breast-cancer-update-757579/episodes/metastatic-breast-cancer-optimizing-the-use-of-oral-selective-estrogen-receptor-degraders-part-2/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/breast-cancer-update-757579/metastatic-breast-cancer-optimizing-the-use-of-oral-selective-estrogen-receptor-degraders-part-2.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Dr Rinath M Jeselsohn and Dr Joyce O’Shaughnessy review current literature and datasets exploring the use of oral selective estrogen receptor degraders for the management of metastatic breast cancer.  CME information and select publications here .